Safety and efficacy of GLP-1RA in IBD assessed through:Clinical severity scores (HBI or mMayo)Endoscopic scores (SES-CD or MES)IBD-related hospitalizationsChange in CRP. Here, CRP is linked to inflammatory bowel disease.